(Q38359030)

2 September 2017

1 reference

title

Lipodystrophy: Syndrome of severe insulin resistance (English)

1 reference

2 September 2017

1 reference

Shagun Bindlish

1

1 reference

2 September 2017

Lubaina S Presswala

series ordinal

2

1 reference

2 September 2017

Frank Schwartz

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

17 February 2015

1 reference

2 September 2017

published in

Postgraduate Medicine

1 reference

2 September 2017

volume

127

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

511-516

1 reference

The adipocyte life cycle hypothesis

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Evidence of impaired adipogenesis in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Insulin resistance in human partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Lipodystrophy: metabolic insights from a rare disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Structure/function of cytoplasmic vitamin A-binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Eucaloric Substitution of Medium Chain Triglycerides for Dietary Long Chain Fatty Acids in Acquired Total Lipodystrophy: Effects on Hyperlipoproteinemia and Endogenous Insulin Resistance*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

The liver diseases of lipodystrophy: the long-term effect of leptin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety e

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1015927

10.1080/00325481.2015.1015927

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference